BENITEC BIOPHARMA INC (BNTC): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in BNTC · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
7
13F filers
Aggregate Value
$54.0M
Across holders
Last Price
$12.71
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity3 increased2 reduced2 exited
Full exits: MARSHALL WACE, LLP, Brevan Howard Capital Management LP
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 2.12M | $28.4M | 52.6% | 0.0% | Unchanged | +$0 | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 921K | $12.3M | 22.8% | 0.0% | Added | +$3.6M | Q2 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 651K | $8.7M | 16.1% | 0.0% | Reduced | $-45K | Q2 2026 |
| Schonfeld Strategic Advisors LLC CIK 0001665241 | Hedge Fund | 235K | $3.1M | 5.8% | 0.0% | Added | +$1.1M | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 81K | $1.1M | 2.0% | 0.0% | Reduced | $-1.2M | Q2 2026 |
| AQR CAPITAL MANAGEMENT LLC CIK 0001167557 | Hedge Fund | 22K | $301K | 0.6% | 0.0% | Added | — | Q2 2026 |
| Rockefeller Capital Management L.P. CIK 0001739439 | Hedge Fund | 582 | $8K | 0.0% | 0.0% | Unchanged | +$0 | Q2 2026 |
Unchanged
Hedge Fund
$28.4M· 52.6% of total· 0.0% port· 2.12M sh· +$0 QoQ· Q2 2026
Added
Hedge Fund
$12.3M· 22.8% of total· 0.0% port· 921K sh· +$3.6M QoQ· Q2 2026
Reduced
Hedge Fund
$8.7M· 16.1% of total· 0.0% port· 651K sh· $-45K QoQ· Q2 2026
Added
Hedge Fund
$3.1M· 5.8% of total· 0.0% port· 235K sh· +$1.1M QoQ· Q2 2026
Reduced
Hedge Fund
$1.1M· 2.0% of total· 0.0% port· 81K sh· $-1.2M QoQ· Q2 2026
Added
Hedge Fund
$301K· 0.6% of total· 0.0% port· 22K sh· — QoQ· Q2 2026
Unchanged
Hedge Fund
$8K· 0.0% of total· 0.0% port· 582 sh· +$0 QoQ· Q2 2026
Loading recent insider activity…